BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19167101)

  • 1. Aspirin resistance: what the cardiologist needs to know?
    Tousoulis D; Siasos G; Stefanadis C
    Int J Cardiol; 2009 Feb; 132(2):153-6. PubMed ID: 19167101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical importance of aspirin resistance].
    Hirmerová J; Filipovský J
    Vnitr Lek; 2004 Jun; 50(6):462-9. PubMed ID: 15346640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin resistance.
    Tran HA; Anand SS; Hankey GJ; Eikelboom JW
    Thromb Res; 2007; 120(3):337-46. PubMed ID: 17241655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of aspirin resistance.
    Patel D; Moonis M
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):969-75. PubMed ID: 17867925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin resistance in stroke: 2004.
    Sztriha LK; Sas K; Vecsei L
    J Neurol Sci; 2005 Mar; 229-230():163-9. PubMed ID: 15760636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population.
    Faraday N; Becker DM; Yanek LR; Herrera-Galeano JE; Segal JB; Moy TF; Bray PF; Becker LC
    Am J Cardiol; 2006 Sep; 98(6):774-9. PubMed ID: 16950183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".
    Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C
    J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin resistance: focus on clinical endpoints.
    Pusch G; Feher G; Kotai K; Tibold A; Gasztonyi B; Feher A; Papp E; Lupkovics G; Szapary L
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):475-84. PubMed ID: 19034037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A current problem in atherothrombotic diseases--aspirin resistance: definition, mechanisms, determination with laboratory tests and clinical implications].
    Pamukçu B; Oflaz H; Nişanci Y
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():20-6. PubMed ID: 18160363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can aspirin resistance be clinically predicted in stroke patients?
    Seok JI; Joo IS; Yoon JH; Choi YJ; Lee PH; Huh K; Bang OY
    Clin Neurol Neurosurg; 2008 Feb; 110(2):110-6. PubMed ID: 17964711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of aspirin in cardiovascular prevention: implications of aspirin resistance.
    Gasparyan AY; Watson T; Lip GY
    J Am Coll Cardiol; 2008 May; 51(19):1829-43. PubMed ID: 18466797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of biological relevance of platelet cyclooxygenase-2 dependent thromboxane A2 production.
    Riondino S; Trifirò E; Principessa L; Mascioletti S; Di Renzo L; Gaudio C; Biasucci LM; Crea F; Pulcinelli FM
    Thromb Res; 2008; 122(3):359-65. PubMed ID: 18295304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a definition of aspirin resistance: a typological approach.
    Weber AA; Przytulski B; Schanz A; Hohlfeld T; Schrör K
    Platelets; 2002 Feb; 13(1):37-40. PubMed ID: 11918835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug insight: aspirin resistance--fact or fashion?
    Patrono C; Rocca B
    Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):42-50. PubMed ID: 17180149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin resistance in cardiovascular disease: a review.
    Wong S; Appleberg M; Ward CM; Lewis DR
    Eur J Vasc Endovasc Surg; 2004 May; 27(5):456-65. PubMed ID: 15079767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aspirin resistance controversy: clinical entity or platelet heterogeneity?
    Freedman JE
    Circulation; 2006 Jun; 113(25):2865-7. PubMed ID: 16801473
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspirin resistance: disparities and clinical implications.
    Airee A; Draper HM; Finks SW
    Pharmacotherapy; 2008 Aug; 28(8):999-1018. PubMed ID: 18657017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin resistance: is this term meaningful?
    Violi F; Pignatelli P
    Curr Opin Hematol; 2006 Sep; 13(5):331-6. PubMed ID: 16888437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.
    Velik-Salchner C; Maier S; Innerhofer P; Kolbitsch C; Streif W; Mittermayr M; Praxmarer M; Fries D
    Anesth Analg; 2009 Jun; 108(6):1747-54. PubMed ID: 19448196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.